Jimmy John N. Novero

Recommended Articles

• Pristiq vs. Effexor

  Pristiq and Effexor are medications that have similar compositions and are produced by the same manufacturing company. Pristiq (desvenlafaxine) is an antidepressant, which has been recently approved by the FDA. The composition of Pristiq is similar to Wyeth’s existing antidepressant. The patent...

• Health Care Reform in Washington Affects Parkinson's Disease Patients

  Lately, and especially during these last 150 days, there has been a predominant debate in the Congress. The controversy around the debate begins with the potentially negative impact this new legislation may be covering. Community affected by this decision have already made their opinion public,...

• Organizations that Support Parkinson's Disease Patients and their Families

  Parkinson’s disease is a neuromuscular degenerative disorder that robs those afflicted of their motor functions over time. The average age of a Parkinson’s diagnosis is somewhere around the age of sixty, though at times those that are younger can also be diagnosed with the disease. Cases such as...

• As Multiple Sclerosis Urgency Increases, Prices Are Projected to Rise

  Access to affordable health care has been a fundamental question for all developed nations, and remains particularly relevant to the United States today. It is crucial that patients with chronic or life-threatening illnesses have continuous access to quality health care, and that the cost of that...

• Sleep Apnea CPAP Machine: Gel, Cleaner, and Price

  Sleep apnea is a sleep breathing disorder. It is characterized by repetitive pauses in breathing, which may occur several times per hour and may last for 10 seconds. It is usually a chronic condition. It results in poor sleep quality and excessive sleepiness in daytime. The most common type is...

• 10 Tips on Living with Insomnia

  .................................................................................................................................................................................................................................................................................................................................................................................People...